Breast tissue may be called dense if there is a lot of fibrous or glandular tissue and not much fat in the breasts. Some women have more dense breasts than others do, and for most women, breasts become less dense with age but for some there is little change. Breast density is seen only on mammograms and is not based on how breasts feel or related to breast size or firmness.7 For women with dense breasts, the American Society of Breast Surgeons recommends supplemental imaging such as breast MRI or ultrasound be considered in addition to annual mammography.8 For women with personal histories of breast cancer and dense breasts, the American College of Radiology recommends an annual breast MRI.9 As such, it is important for women to ask their doctor if additional breast screening might be right for them.
“Mammograms may be limited in women with dense breasts as both dense tissue and tumors may look white on a mammogram. Supplemental screening, such as breast MRI or ultrasound, may be recomended depending on individual patient risk factors and can help detect cancer earlier in dense breasts. Timing is critical as earlier detection can lead to increased survival rates,” said Victoria L. Mango, M.D., Breast Radiologist, Memorial Sloan Kettering Cancer Center, New York. “As nearly 50% of women over the age of 40 who have mammograms are found to have dense breasts, educating women on their breast density is an important step in better understanding their overall breast health and screening needs"
Dr. Victoria Mango has a consulting relationship with Bayer.
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to bayer.us.
Bayer® and the Bayer Cross® are registered trademarks of Bayer.
About HealthyWomen
HealthyWomen is the nation's leading independent, nonprofit health information source for women. Our mission is to educate, engage and inspire women, ages 35 to 64, to make informed health choices to live and age well. We engage with healthcare professionals, patient advocates, policy makers, NGOs and corporate partners to better inform our educational resources so that we can provide our audience with the most reliable, medically-accurate, balanced health information.
Back to HCB News
